The enzyme replacement therapy (ERT) market is projected to grow significantly, rising from US$ 10,707.6 million in ...

In India, 32 patients, diagnosed with this condition by the Centres of Excellence (CoEs), have registered themselves with the ...

nbsp, Ceredase and Cerezyme, changed the lives of Gaucher disease patients, but the Ceredase price has changed the lives beyond Gaucher patients. It was proof of a viable business model.

Together the organisations are developing algorithms for identifying Fabry and Gaucher patients through ... with Microsoft and European rare disease patient alliance Eurordis on the Global ...

It acquired rights to taligurase alfa, a form of the enzyme glucocerebrosidase in development for the treatment of Gaucher's disease, from Protalix Biotherapeutics in Carmiel, Israel. Protalix has ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Pregnancy Complications Linked to Cardiovascular Disease in the Family Feb. 7, 2025 — Women who have experienced pregnancy complications have an increased risk of cardiovascular disease.